- Home
- LH vs WST Comparison
LH vs WST Comparison
Compare LH & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LH
- WST
- Stock Information
- Founded
- LH 1971
- WST 1923
- Country
- LH United States
- WST United States
- Employees
- LH N/A
- WST N/A
- Industry
- LH Medical Specialities
- WST Medical/Dental Instruments
- Sector
- LH Health Care
- WST Health Care
- Exchange
- LH Nasdaq
- WST Nasdaq
- Market Cap
- LH 23.1B
- WST 18.9B
- IPO Year
- LH N/A
- WST N/A
- Fundamental
- Price
- LH $274.17
- WST $258.35
- Analyst Decision
- LH Strong Buy
- WST Strong Buy
- Analyst Count
- LH 13
- WST 8
- Target Price
- LH $290.00
- WST $329.43
- AVG Volume (30 Days)
- LH 435.4K
- WST 549.8K
- Earning Date
- LH 10-23-2025
- WST 10-23-2025
- Dividend Yield
- LH 1.05%
- WST 0.34%
- EPS Growth
- LH 72.08
- WST N/A
- EPS
- LH 9.07
- WST 6.68
- Revenue
- LH $13,483,800,000.00
- WST $2,960,200,000.00
- Revenue This Year
- LH $10.89
- WST $6.28
- Revenue Next Year
- LH $4.78
- WST $6.02
- P/E Ratio
- LH $30.23
- WST $38.69
- Revenue Growth
- LH 7.98
- WST 2.90
- 52 Week Low
- LH $209.38
- WST $187.43
- 52 Week High
- LH $283.47
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- LH 51.19
- WST 60.16
- Support Level
- LH $270.00
- WST $253.38
- Resistance Level
- LH $281.69
- WST $264.06
- Average True Range (ATR)
- LH 4.45
- WST 5.67
- MACD
- LH -0.83
- WST 0.60
- Stochastic Oscillator
- LH 35.67
- WST 74.53
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.